← Back to directory

Francisco J. Blanco

Researcher Next ID · RN-035148

Researcher · Medicine

Universidade da Coruña

A Coruña, Spain

Accepting doctoral researchersFunding unknown
Works count
1,161
Citation count
30,648
H-index
83
i10-index
406

Research interests

Medicine
Osteoarthritis Treatment and Mechanisms
Rheumatoid Arthritis Research and Therapies
Inflammatory mediators and NSAID effects
Spondyloarthritis Studies and Treatments
Systemic Lupus Erythematosus Research

Publications

  • OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

    Osteoarthritis and Cartilage · 2019 · https://doi.org/10.1016/j.joca.2019.06.011

  • A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

    Arthritis & Rheumatology · 2019 · 10.1002/art.40840

  • GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-12760-y

  • 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    Annals of the Rheumatic Diseases · 2018 · 10.1136/annrheumdis-2018-213826

  • Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes

    Nature Reviews Rheumatology · 2018 · https://doi.org/10.1038/s41584-018-0001-0

  • Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)31429-0

  • Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

    Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-208918

  • Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)

    Annals of the Rheumatic Diseases · 2016 · 10.1136/annrheumdis-2015-207963

  • Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

    Osteoarthritis and Cartilage · 2015 · https://doi.org/10.1016/j.joca.2015.03.036

  • Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

    Annals of the Rheumatic Diseases · 2015 · https://doi.org/10.1136/annrheumdis-2014-206792

  • Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

    Nature Communications · 2015 · https://doi.org/10.1038/ncomms8146

  • The role of mitochondria in osteoarthritis

    Nature Reviews Rheumatology · 2011 · 10.1038/nrrheum.2010.213

  • Autophagy activation by rapamycin reduces severity of experimental osteoarthritis

    Annals of the Rheumatic Diseases · 2011 · 10.1136/annrheumdis-2011-200557

  • Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis

    Arthritis & Rheumatism · 2010 · 10.1002/art.27431

  • Autophagy is a protective mechanism in normal cartilage, and its aging‐related loss is linked with cell death and osteoarthritis

    Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27305

  • Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

    AIDS · 2009 · 10.1097/qad.0b013e3283262a64

  • Mitochondrial Dysregulation of Osteoarthritic Human Articular Chondrocytes Analyzed by Proteomics

    Molecular & Cellular Proteomics · 2008 · https://doi.org/10.1074/mcp.m800292-mcp200

  • Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: A randomized, double‐blind, placebo‐controlled study using acetaminophen as a side comparator

    Arthritis & Rheumatism · 2007 · 10.1002/art.22371

  • Cell Death and Apoptosis in Ostearthritic Cartilage

    Current Drug Targets · 2007 · https://doi.org/10.2174/138945007779940025

  • Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes

    Osteoarthritis and Cartilage · 2006 · 10.1016/j.joca.2006.01.005

  • Mitochondrial dysfunction in osteoarthritis

    Mitochondrion · 2004 · https://doi.org/10.1016/j.mito.2004.07.022

  • Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes

    Arthritis & Rheumatism · 2003 · 10.1002/art.10837

  • Osteoarthritis chondrocytes die by apoptosis: A possible pathway for osteoarthritis pathology

    Arthritis & Rheumatism · 1998 · https://doi.org/10.1002/1529-0131(199802)41:2<284::aid-art12>3.0.co;2-t

  • Chondrocyte apoptosis induced by nitric oxide.

    PubMed · 1995

  • Growth factor responsiveness of human articular chondrocytes in aging and development

    Arthritis & Rheumatism · 1995 · https://doi.org/10.1002/art.1780380712

Current projects

    No projects listed.